Literature DB >> 22042863

Mst1 and Mst2 protein kinases restrain intestinal stem cell proliferation and colonic tumorigenesis by inhibition of Yes-associated protein (Yap) overabundance.

Dawang Zhou1, Yongyou Zhang, Hongtan Wu, Evan Barry, Yi Yin, Earl Lawrence, Dawn Dawson, Joseph E Willis, Sanford D Markowitz, Fernando D Camargo, Joseph Avruch.   

Abstract

Ablation of the kinases Mst1 and Mst2, orthologs of the Drosophila antiproliferative kinase Hippo, from mouse intestinal epithelium caused marked expansion of an undifferentiated stem cell compartment and loss of secretory cells throughout the small and large intestine. Although median survival of mice lacking intestinal Mst1/Mst2 is 13 wk, adenomas of the distal colon are common by this age. Diminished phosphorylation, enhanced abundance, and nuclear localization of the transcriptional coactivator Yes-associated protein 1 (Yap1) is evident in Mst1/Mst2-deficient intestinal epithelium, as is strong activation of β-catenin and Notch signaling. Although biallelic deletion of Yap1 from intestinal epithelium has little effect on intestinal development, inactivation of a single Yap1 allele reduces Yap1 polypeptide abundance to nearly wild-type levels and, despite the continued Yap hypophosphorylation and preferential nuclear localization, normalizes epithelial structure. Thus, supraphysiologic Yap polypeptide levels are necessary to drive intestinal stem cell proliferation. Yap is overexpressed in 68 of 71 human colon cancers and in at least 30 of 36 colon cancer-derived cell lines. In colon-derived cell lines where Yap is overabundant, its depletion strongly reduces β-catenin and Notch signaling and inhibits proliferation and survival. These findings demonstrate that Mst1 and Mst2 actively suppress Yap1 abundance and action in normal intestinal epithelium, an antiproliferative function that frequently is overcome in colon cancer through Yap1 polypeptide overabundance. The dispensability of Yap1 in normal intestinal homeostasis and its potent proliferative and prosurvival actions when overexpressed in colon cancer make it an attractive therapeutic target.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22042863      PMCID: PMC3241824          DOI: 10.1073/pnas.1110428108

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  46 in total

1.  Control of endodermal endocrine development by Hes-1.

Authors:  J Jensen; E E Pedersen; P Galante; J Hald; R S Heller; M Ishibashi; R Kageyama; F Guillemot; P Serup; O D Madsen
Journal:  Nat Genet       Date:  2000-01       Impact factor: 38.330

2.  The Nore1B/Mst1 complex restrains antigen receptor-induced proliferation of naïve T cells.

Authors:  Dawang Zhou; Benjamin D Medoff; Lanfen Chen; Lequn Li; Xian-feng Zhang; Maria Praskova; Matthew Liu; Aimee Landry; Richard S Blumberg; Vassiliki A Boussiotis; Ramnik Xavier; Joseph Avruch
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-10       Impact factor: 11.205

3.  IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer.

Authors:  Sergei Grivennikov; Eliad Karin; Janos Terzic; Daniel Mucida; Guann-Yi Yu; Sivakumar Vallabhapurapu; Jürgen Scheller; Stefan Rose-John; Hilde Cheroutre; Lars Eckmann; Michael Karin
Journal:  Cancer Cell       Date:  2009-02-03       Impact factor: 31.743

4.  Single-cell cloning of colon cancer stem cells reveals a multi-lineage differentiation capacity.

Authors:  L Vermeulen; M Todaro; F de Sousa Mello; M R Sprick; K Kemper; M Perez Alea; D J Richel; G Stassi; J P Medema
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-02       Impact factor: 11.205

5.  TEAD mediates YAP-dependent gene induction and growth control.

Authors:  Bin Zhao; Xin Ye; Jindan Yu; Li Li; Weiquan Li; Siming Li; Jianjun Yu; Jiandie D Lin; Cun-Yu Wang; Arul M Chinnaiyan; Zhi-Chun Lai; Kun-Liang Guan
Journal:  Genes Dev       Date:  2008-06-25       Impact factor: 11.361

6.  Transcription factor achaete scute-like 2 controls intestinal stem cell fate.

Authors:  Laurens G van der Flier; Marielle E van Gijn; Pantelis Hatzis; Pekka Kujala; Andrea Haegebarth; Daniel E Stange; Harry Begthel; Maaike van den Born; Victor Guryev; Irma Oving; Johan H van Es; Nick Barker; Peter J Peters; Marc van de Wetering; Hans Clevers
Journal:  Cell       Date:  2009-03-06       Impact factor: 41.582

7.  Prominin-1/CD133 marks stem cells and early progenitors in mouse small intestine.

Authors:  Hugo J Snippert; Johan H van Es; Maaike van den Born; Harry Begthel; Daniel E Stange; Nick Barker; Hans Clevers
Journal:  Gastroenterology       Date:  2009-03-24       Impact factor: 22.682

8.  Jagged1 is the pathological link between Wnt and Notch pathways in colorectal cancer.

Authors:  Verónica Rodilla; Alberto Villanueva; Antonia Obrador-Hevia; Alex Robert-Moreno; Vanessa Fernández-Majada; Andrea Grilli; Nuria López-Bigas; Nicolás Bellora; M Mar Albà; Ferran Torres; Mireia Duñach; Xavier Sanjuan; Sara Gonzalez; Thomas Gridley; Gabriel Capella; Anna Bigas; Lluís Espinosa
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-26       Impact factor: 11.205

9.  Notch and Wnt signals cooperatively control cell proliferation and tumorigenesis in the intestine.

Authors:  Silvia Fre; S K Pallavi; Mathilde Huyghe; Marick Laé; Klaus-Peter Janssen; Sylvie Robine; Spyros Artavanis-Tsakonas; Daniel Louvard
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-27       Impact factor: 11.205

10.  Prominin 1 marks intestinal stem cells that are susceptible to neoplastic transformation.

Authors:  Liqin Zhu; Paul Gibson; D Spencer Currle; Yiai Tong; Robert J Richardson; Ildar T Bayazitov; Helen Poppleton; Stanislav Zakharenko; David W Ellison; Richard J Gilbertson
Journal:  Nature       Date:  2008-12-17       Impact factor: 49.962

View more
  212 in total

Review 1.  The Hippo pathway regulates stem cell proliferation, self-renewal, and differentiation.

Authors:  Huan Liu; Dandan Jiang; Fangtao Chi; Bin Zhao
Journal:  Protein Cell       Date:  2012-05-02       Impact factor: 14.870

Review 2.  Hippo pathway in intestinal homeostasis and tumorigenesis.

Authors:  Lanfen Chen; Funiu Qin; Xianming Deng; Joseph Avruch; Dawang Zhou
Journal:  Protein Cell       Date:  2012-04-10       Impact factor: 14.870

Review 3.  Targeting the Hippo pathway in cancer, fibrosis, wound healing and regenerative medicine.

Authors:  Anwesha Dey; Xaralabos Varelas; Kun-Liang Guan
Journal:  Nat Rev Drug Discov       Date:  2020-06-17       Impact factor: 84.694

Review 4.  Recent Advances of the Hippo/YAP Signaling Pathway in Brain Development and Glioma.

Authors:  Taohui Ouyang; Wei Meng; Meihua Li; Tao Hong; Na Zhang
Journal:  Cell Mol Neurobiol       Date:  2019-11-25       Impact factor: 5.046

5.  The hippo tumor suppressor network: from organ size control to stem cells and cancer.

Authors:  Georg Halder; Fernando D Camargo
Journal:  Cancer Res       Date:  2013-09-10       Impact factor: 12.701

6.  Repression of Intestinal Stem Cell Function and Tumorigenesis through Direct Phosphorylation of β-Catenin and Yap by PKCζ.

Authors:  Victoria Llado; Yuki Nakanishi; Angeles Duran; Miguel Reina-Campos; Phillip M Shelton; Juan F Linares; Tomoko Yajima; Alex Campos; Pedro Aza-Blanc; Michael Leitges; Maria T Diaz-Meco; Jorge Moscat
Journal:  Cell Rep       Date:  2015-02-05       Impact factor: 9.423

7.  Colon cancer cells escape 5FU chemotherapy-induced cell death by entering stemness and quiescence associated with the c-Yes/YAP axis.

Authors:  Yasmine Touil; Wassila Igoudjil; Matthieu Corvaisier; Anne-Frédérique Dessein; Jérôme Vandomme; Didier Monté; Laurence Stechly; Nicolas Skrypek; Carole Langlois; Georges Grard; Guillaume Millet; Emmanuelle Leteurtre; Patrick Dumont; Stéphanie Truant; François-René Pruvot; Mohamed Hebbar; Fan Fan; Lee M Ellis; Pierre Formstecher; Isabelle Van Seuningen; Christian Gespach; Renata Polakowska; Guillemette Huet
Journal:  Clin Cancer Res       Date:  2013-12-09       Impact factor: 12.531

8.  Colon cancer stem cells: Potential target for the treatment of colorectal cancer.

Authors:  Riya Gupta; Lokesh Kumar Bhatt; Thomas P Johnston; Kedar S Prabhavalkar
Journal:  Cancer Biol Ther       Date:  2019-05-03       Impact factor: 4.742

9.  Hippo signaling regulates differentiation and maintenance in the exocrine pancreas.

Authors:  Tao Gao; Dawang Zhou; Chenghua Yang; Tarjinder Singh; Alfredo Penzo-Méndez; Ravikanth Maddipati; Alexandros Tzatsos; Nabeel Bardeesy; Joseph Avruch; Ben Z Stanger
Journal:  Gastroenterology       Date:  2013-02-27       Impact factor: 22.682

10.  G protein-coupled receptors engage the mammalian Hippo pathway through F-actin: F-Actin, assembled in response to Galpha12/13 induced RhoA-GTP, promotes dephosphorylation and activation of the YAP oncogene.

Authors:  Laura Regué; Fan Mou; Joseph Avruch
Journal:  Bioessays       Date:  2013-03-01       Impact factor: 4.345

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.